US Stock MarketDetailed Quotes

Nymox Pharmaceutical (NYMXF)

Watchlist
  • 0.0654
  • +0.0154+30.80%
15min DelayClose May 13 13:49 ET
6.18MMarket Cap-1.31P/E (TTM)

Nymox Pharmaceutical (NYMXF) Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
35.89%-2.6M
20.07%-717K
22.06%-4.06M
28.18%-897K
3.29%-1.26M
-158.38%-909K
76.52%-988K
47.00%-5.21M
44.46%-1.25M
56.47%-1.31M
Net income from continuing operations
49.21%-4.49M
83.86%-857K
-34.49%-8.84M
-296.64%-5.31M
30.52%-1.04M
-182.84%-1.11M
72.73%-1.39M
47.55%-6.58M
52.35%-1.34M
54.79%-1.49M
Depreciation and amortization
-99.41%1K
--0
-32.13%169K
-81.97%11K
-32.79%41K
-7.94%58K
-7.81%59K
-1.97%249K
-4.69%61K
-3.17%61K
Other non cash items
----
----
--440K
----
----
----
----
----
----
----
Change In working capital
48.48%1.22M
-102.64%-19K
65.86%821K
907.87%719K
-406.59%-279K
148.68%111K
-62.55%270K
453.57%495K
60.27%-89K
49.18%91K
-Change in receivables
-1,500.00%-16K
0.00%-4K
-133.33%-1K
---4K
400.00%3K
--0
--0
-57.14%3K
--0
-133.33%-1K
-Change in inventory
----
----
----
----
----
----
--0
----
----
----
-Change in prepaid assets
98.40%-8K
-74.07%7K
-531.03%-500K
-77.31%27K
-442.39%-499K
-72.82%28K
-300.00%-56K
544.44%116K
1,800.00%119K
22.03%-92K
-Change in payables and accrued expense
-5.98%1.24M
-103.16%-22K
251.60%1.32M
434.62%696K
17.93%217K
125.00%83K
-55.46%326K
327.88%376K
3.70%-208K
4.55%184K
Cash from discontinued investing activities
Operating cash flow
35.89%-2.6M
20.07%-717K
22.06%-4.06M
28.18%-897K
3.29%-1.26M
-158.38%-909K
76.52%-988K
47.00%-5.21M
44.46%-1.25M
56.47%-1.31M
Investing cash flow
Cash flow from continuing investing activities
0
0
-3K
0
0
0
-3K
0
0
0
Net PPE purchase and sale
--0
--0
---3K
--0
--0
--0
---3K
--0
--0
--0
Cash from discontinued investing activities
Investing cash flow
--0
--0
---3K
--0
--0
--0
---3K
--0
--0
--0
Financing cash flow
Cash flow from continuing financing activities
-4.47%2.61M
-15.82%750K
-52.80%2.73M
1,813.46%891K
2,111.67%1.21M
-62.52%690K
-101.51%-61K
-17.98%5.78M
11.86%-52K
-1.69%-60K
Net issuance payments of debt
65.19%2.61M
251.55%2.61M
788.65%1.58M
1,525.00%741K
445.00%207K
1,289.66%690K
-3.39%-61K
3.78%-229K
11.86%-52K
-1.69%-60K
Net common stock issuance
--0
-1,336.67%-1.86M
-80.86%1.15M
--150K
--1M
--0
--0
-17.52%6.01M
--0
--0
Cash from discontinued financing activities
Financing cash flow
-4.47%2.61M
-15.82%750K
-52.80%2.73M
1,813.46%891K
2,111.67%1.21M
-62.52%690K
-101.51%-61K
-17.98%5.78M
11.86%-52K
-1.69%-60K
Net cash flow
Beginning cash position
-95.01%70K
-46.05%41K
69.04%1.4M
-97.19%76K
-96.76%132K
-47.77%351K
69.04%1.4M
-77.01%830K
-13.94%2.7M
-34.37%4.07M
Current changes in cash
100.30%4K
650.00%33K
-332.64%-1.33M
99.54%-6K
95.90%-56K
-106.44%-219K
-565.82%-1.05M
120.60%573K
43.73%-1.3M
55.34%-1.37M
End cash Position
5.71%74K
5.71%74K
-95.01%70K
-95.01%70K
-97.19%76K
-96.76%132K
-47.77%351K
69.04%1.4M
69.04%1.4M
-13.94%2.7M
Free cash flow
35.94%-2.6M
20.07%-717K
22.00%-4.06M
28.18%-897K
3.29%-1.26M
-158.38%-909K
76.44%-991K
47.03%-5.21M
44.56%-1.25M
56.47%-1.31M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion with Explanatory Notes
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
(FY)Dec 31, 2024(Q4)Dec 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 35.89%-2.6M20.07%-717K22.06%-4.06M28.18%-897K3.29%-1.26M-158.38%-909K76.52%-988K47.00%-5.21M44.46%-1.25M56.47%-1.31M
Net income from continuing operations 49.21%-4.49M83.86%-857K-34.49%-8.84M-296.64%-5.31M30.52%-1.04M-182.84%-1.11M72.73%-1.39M47.55%-6.58M52.35%-1.34M54.79%-1.49M
Depreciation and amortization -99.41%1K--0-32.13%169K-81.97%11K-32.79%41K-7.94%58K-7.81%59K-1.97%249K-4.69%61K-3.17%61K
Other non cash items ----------440K----------------------------
Change In working capital 48.48%1.22M-102.64%-19K65.86%821K907.87%719K-406.59%-279K148.68%111K-62.55%270K453.57%495K60.27%-89K49.18%91K
-Change in receivables -1,500.00%-16K0.00%-4K-133.33%-1K---4K400.00%3K--0--0-57.14%3K--0-133.33%-1K
-Change in inventory --------------------------0------------
-Change in prepaid assets 98.40%-8K-74.07%7K-531.03%-500K-77.31%27K-442.39%-499K-72.82%28K-300.00%-56K544.44%116K1,800.00%119K22.03%-92K
-Change in payables and accrued expense -5.98%1.24M-103.16%-22K251.60%1.32M434.62%696K17.93%217K125.00%83K-55.46%326K327.88%376K3.70%-208K4.55%184K
Cash from discontinued investing activities
Operating cash flow 35.89%-2.6M20.07%-717K22.06%-4.06M28.18%-897K3.29%-1.26M-158.38%-909K76.52%-988K47.00%-5.21M44.46%-1.25M56.47%-1.31M
Investing cash flow
Cash flow from continuing investing activities 00-3K000-3K000
Net PPE purchase and sale --0--0---3K--0--0--0---3K--0--0--0
Cash from discontinued investing activities
Investing cash flow --0--0---3K--0--0--0---3K--0--0--0
Financing cash flow
Cash flow from continuing financing activities -4.47%2.61M-15.82%750K-52.80%2.73M1,813.46%891K2,111.67%1.21M-62.52%690K-101.51%-61K-17.98%5.78M11.86%-52K-1.69%-60K
Net issuance payments of debt 65.19%2.61M251.55%2.61M788.65%1.58M1,525.00%741K445.00%207K1,289.66%690K-3.39%-61K3.78%-229K11.86%-52K-1.69%-60K
Net common stock issuance --0-1,336.67%-1.86M-80.86%1.15M--150K--1M--0--0-17.52%6.01M--0--0
Cash from discontinued financing activities
Financing cash flow -4.47%2.61M-15.82%750K-52.80%2.73M1,813.46%891K2,111.67%1.21M-62.52%690K-101.51%-61K-17.98%5.78M11.86%-52K-1.69%-60K
Net cash flow
Beginning cash position -95.01%70K-46.05%41K69.04%1.4M-97.19%76K-96.76%132K-47.77%351K69.04%1.4M-77.01%830K-13.94%2.7M-34.37%4.07M
Current changes in cash 100.30%4K650.00%33K-332.64%-1.33M99.54%-6K95.90%-56K-106.44%-219K-565.82%-1.05M120.60%573K43.73%-1.3M55.34%-1.37M
End cash Position 5.71%74K5.71%74K-95.01%70K-95.01%70K-97.19%76K-96.76%132K-47.77%351K69.04%1.4M69.04%1.4M-13.94%2.7M
Free cash flow 35.94%-2.6M20.07%-717K22.00%-4.06M28.18%-897K3.29%-1.26M-158.38%-909K76.44%-991K47.03%-5.21M44.56%-1.25M56.47%-1.31M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion with Explanatory Notes--Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes----
Market Insights
China Concept Stocks
View More
Middle East conflict spreads to the stock market! How should investors respond?
According to Axios, on Sunday local time, Trump rejected Iran's latest ceasefire proposal, prompting a sharp response from Iran: no one woul Show More